748
Views
0
CrossRef citations to date
0
Altmetric
Empirical Studies

A qualitative study on the facilitators and barriers to adopting the N-of-1 trial methodology as part of clinical practice: potential versus implementation challenges

ORCID Icon, &
Article: 2318810 | Received 07 Nov 2023, Accepted 10 Feb 2024, Published online: 28 Feb 2024

References

  • Bietz, M., Patrick, K., & Bloss, C. (2019). Data donation as a model for citizen science health research. Citizen Science: Theory and Practice, 4(1), 1–19. https://doi.org/10.5334/cstp.178
  • Blackston, J. W., Chapple, A. G., McGree, J. M., McDonald, S., & Nikles, J. (2019). Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies. Healthcare, 7(4), 137. https://doi.org/10.3390/healthcare7040137.
  • Bradbury, J., Avila, C., & Grace, S. (2020). Practice-Based Research in Complementary Medicine: Could N-of-1 Trials Become the New Gold Standard? Healthcare, 8(1), 15. https://doi.org/10.3390/healthcare8010015
  • Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
  • Braun, V., & Clarke, V. (2012). Thematic analysis. In H. Cooper, P. Camic, D. Long, A. Panter, D. Rindskopf, & K. Sher (Eds.), APA Handbook of Research Methods in psychology, Research designs: Quantitative, qualitative, neuropsychological, and biological. APA handbooks in psychology. (vol 2, pp. 57–71). American Psychological Association. https://doi.org/10.1037/13620-004
  • Byrne, D. (2022). A worked example of Braun and Clarke’s approach to reflexive thematic analysis. Quality & Quantity, 56(3), 1391–1412. https://doi.org/10.1007/s11135-021-01182-y
  • Clough, A. J., Hilmer, S. N., Naismith, S. L., Kardell, L. D., & Gnjidic, D. (2018). N-of-1 trials for assessing the effects of deprescribing medications on short-term clinical outcomes in older adults: A systematic review. Journal of Clinical Epidemiology, 93, 112–119. https://doi.org/10.1016/j.jclinepi.2017.09.015
  • Cook, D. J., Jaeschke, R., & Guyatt, G. H. (1992). Critical appraisal of therapeutic interventions in the intensive care unit: Human monoclonal antibody treatment in sepsis. Journal of Intensive Care Medicine, 7(6), 275–282. https://doi.org/10.1177/088506669200700601
  • Coppini, G., & Colantonio, S. (2017). Self-monitoring systems for personalised health-care and lifestyle surveillance. Computers in Biology and Medicine, 88, 161–162. https://doi.org/10.1016/j.compbiomed.2017.07.011
  • Damschroder, L. J., Aron, D. C., Keith, R. E., Kirsh, S. R., Alexander, J. A., & Lowery, J. C. (2009). Fostering implementation of health services research findings into practice: A consolidated framework for advancing implementation science. Implementation Science: IS, 4(1), 50. https://doi.org/10.1186/1748-5908-4-50
  • Davidson, K. W., Cheung, Y. K., McGinn, T., & Wang, Y. C. (2018). Expanding the role of N-of-1 trials in the precision medicine era: Action priorities and practical considerations. NAM Perspectives, Published online 2018. https://doi.org/10.31478/201812d
  • Dawes, M., Summerskill, W., Glasziou, P., Cartabellotta, A., Martin, J., Hopayian, K., Porzsolt, F., Burls, A., & Osborne, J. (2005). Sicily statement on evidence-based practice. BMC Medical Education, 5(1), 1. https://doi.org/10.1186/1472-6920-5-1
  • Demeyin, W. A., Frost, J., Ukoumunne, O. C., Briscoe, S., & Britten, N. (2017). N of 1 trials and the optimal individualisation of drug treatments: A systematic review protocol. Systematic Review, 6(1), 90. https://doi.org/10.1186/s13643-017-0479-6
  • Den Broeder, L., Devilee, J., Van Oers, H., Schuit, A. J., & Wagemakers, A. (2018). Citizen science for public health. Health Promotion International, 33(3), 505–514. https://doi.org/10.1093/heapro/daw086
  • Greef, J., Martin, S., Juhasz, P., Adourian, A., Plasterer, T., Verheij, E. R., & McBurney, R. N. (2007). The art and practice of systems biology in medicine: Mapping patterns of relationships. Journal of Proteome Research, 6(4), 1540–1559. https://doi.org/10.1021/pr0606530
  • Greenhalgh, T., Howick, J., & Maskrey, N. (2014). Evidence based medicine: A movement in crisis? BMJ, 348, g3725. https://doi.org/10.1136/bmj.g3725
  • Guyatt, G. H., Bombardier, C., & Tugwell, P. X. (1986). Measuring disease-specific quality of life in clinical trials. The Canadian Medical Association Journal, 134(8), 889–895.
  • Guyatt, G. H., Keller, J. L., Jaeschke, R., Rosenbloom, D., Adachi, J. D., & Newhouse, M. T. (1990). The n-of-1 Randomized Controlled Trial: Clinical usefulness. Annals of Internal Medicine, 112(4), 293–299. https://doi.org/10.7326/0003-4819-112-4-293
  • Guyatt, G. H., Sackett, D., Adachi, J., Roberts, R., Chong, J., Rosenbloom, D., & Keller, J. (1988). A clinician’s guide for conducting randomized trials in individual patients. The Canadian Medical Association Journal, 139(6), 497–503.
  • Hasson, S. (1996). Making a case for single case research. The Journal of Orthopaedic and Sports Physical Therapy, 24(1), 1–3. https://doi.org/10.2519/jospt.1996.24.1.1
  • Huang, S., & Hood, L. (2019). Personalized, precision, and N-of-one medicine: A clarification of terminology and concepts. Perspectives in Biology and Medicine, 62(4), 617–639. https://doi.org/10.1353/pbm.2019.0036
  • Ivers, N., Jamtvedt, G., Flottorp, S., Young, J. M., Odgaard-Jensen, J., French, S. D., O’Brien, M. A., Johansen, M., Grimshaw, J., & Oxman, A. D. (2012). Audit and feedback: Effects on professional practice and healthcare outcomes. Cochrane Database of Systematic Reviews, 6, CD000259. https://doi.org/10.1002/14651858.CD000259.pub3
  • Kent, D., Paulus, J., Ahmed, M. & Whicher, D (Eds.). (2019). Caring for the individual patient: Understanding heterogeneous treatment effects. National Academy of Medicine. Retrieved December 21, 2021. https://nam.edu/caring-for-the-individual-patient-special-publication/
  • King, A. C., Winter, S. J., Chrisinger, B. W., Hua, J., & Banchoff, A. W. (2019). Maximizing the promise of citizen science to advance health and prevent disease. Preventive Medicine, 119, 44. https://doi.org/10.1016/j.ypmed.2018.12.016
  • Kravitz, R. L., Duan, N. (2014). Design and implementation of N-of-1 trials: A user’s guide.
  • Kravitz, R. L., Duan, N., Niedzinski, E. J., Hay, M. C., Subramanian, S. K., & Weisner, T. S. (2008). What ever happened to N-of-1 trials? insiders’ perspectives and a look to the future. The Milbank Quarterly, 86(4), 533–555. https://doi.org/10.1111/j.1468-0009.2008.00533.x
  • Kravitz, R. L., Paterniti, D. A., Hay, M. C., Subramanian, S., Dean, D. E., Weisner, T., Vohra, S., & Duan, N. (2009). Marketing therapeutic precision: Potential facilitators and barriers to adoption of n-of-1 trials. Contemporary Clinical Trials, 30(5), 436–445. https://doi.org/10.1016/j.cct.2009.04.001
  • Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry (Vol. 75, 1st ed.). SAGE Publications.
  • Mizra, R. D., Punja, S., Vohra, S., Guyatt, G. (2017). The history and development of N-of-1 trials. Journal of the Royal Society of Medicine, 110(8), 330–340. https://doi.org/10.1177/0141076817721131
  • Nikles, C. J., Mitchell, G. K., Del Mar, C. B., McNairn, N., & Clavarino, A. (2007). Long-term changes in management following n-of-1 trials of stimulants in attention-deficit/hyperactivity disorder. European Journal of Clinical Pharmacology, 63(11), 985–989. https://doi.org/10.1007/s00228-007-0361-x
  • Nikles, J., Mitchell, G. K., Schluter, P., Good, P., Hardy, J., Rowett, D., Shelby-James, T., Vohra, S., & Currow, D. (2011). Aggregating single patient (n-of-1) trials in populations where recruitment and retention was difficult: The case of palliative care. Journal of Clinical Epidemiology, 64(5), 471–480. https://doi.org/10.1016/j.jclinepi.2010.05.009
  • Nowell, L. S., Norris, J. M., White, D. E., & Moules, N. J. (2017). Thematic analysis: Striving to meet the trustworthiness criteria. International Journal of Qualitative Methods, 16(1), 1609406917733847. https://doi.org/10.1177/1609406917733847
  • OCEBM Levels of Evidence Working Group. (2011). The Oxford Levels of Evidence 2. Oxford Centre for Evidence-Based Medicine. Retrieved December 21, 2021, from. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence
  • Porcino, A. J., Shamseer, L., Chan, A. W., Kravitz, R. L., Orkin, A., Punja, S., Ravaud, P., Schmid, C. H., & Vohra, S. (2020). SPIRIT extension and elaboration for n-of-1 trials: SPENT 2019 checklist. BMJ: British Medical Journal, 368. https://doi.org/10.1136/bmj.m122
  • Punja, S., Xu, D., Schmid, C. H., Hartling, L., Urichuk, L., Nikles, C. J., & Vohra, S. (2016). N-of-1 trials can be aggregated to generate group mean treatment effects: A systematic review and meta-analysis. Journal of Clinical Epidemiology, 76, 65–75. https://doi.org/10.1016/j.jclinepi.2016.03.026
  • Rosas, L. G., Espinosa, P. R., Jimenez, F. M., & King, A. C. (2022). The role of citizen science in promoting health equity. Annual Review of Public Health, 43(1), 215–234. https://doi.org/10.1146/annurev-publhealth-090419-102856
  • Rowbotham, S., McKinnon, M., Leach, J., Lamberts, R., & Hawe, P. (2019). Does citizen science have the capacity to transform population health science? Critical Public Health, 29(1), 118–128. https://doi.org/10.1080/09581596.2017.1395393
  • RVS. (2017). Zonder Context Geen Bewijs: Over de Illusie van Evidence-Based Practice in de Zorg. Raad voor Volksgezondheid en Samenleving. Retrieved March 27, 2018, from https://www.raadrvs.nl/uploads/docs/Zonder_context_geen_bewijs.pdf
  • Sacristán, J. A., & Knottnerus, J. A. (2021). Individual point-of-care trials: A new approach to incorporate patient’s preferences into personalized pragmatic clinical trials. Journal of Clinical Epidemiology, 130, 152–155. https://doi.org/10.1016/j.jclinepi.2020.09.038
  • Saldaña, J. (2013). The coding manual for qualitative researchers (2nd ed.). SAGE Publications, Inc.
  • Schork, N. J. (2015). Personalized medicine: Time for one-person trials. Nature, 520(7549), 609. https://doi.org/10.1038/520609a
  • Tong, A., Sainsbury, P., & Craig, J. (2007). Consolidated criteria for reporting qualitative research (COREQ): A 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care: Journal of the International Society for Quality in Health Care / ISQua, 19(6), 349–357. https://doi.org/10.1093/intqhc/mzm042
  • van Oortmerssen, G., Raaijmakers, S., & Sappelli, M. (2017). Analyzing cancer forum discussions with text mining. In: Proceedings of Second International Workshop on Extraction and Processing of Rich Semantics from Medical Texts, Vienna, Austria.
  • Vohra, S., Shamseer, L., Sampson, M., Bukutu, C., Schmid, C. H., Tate, R., Nikles, J., Zucker, D. R., Kravitz, R., Guyatt, G., Altman, D. G., & Moher, D. (2015). CONSORT extension for reporting N-of-1 trials (CENT) 2015 statement. BMJ: British Medical Journal, 350(may 14 17), h1738. https://doi.org/10.1136/bmj.h1738
  • Whitney, R. L., Ward, D. H., Marois, M. T., Schmid, C. H., Sim, I., & Kravitz, R. L. (2018). Patient perceptions of their own data in mHealth technology–enabled N-of-1 trials for chronic pain: Qualitative study. JMIR MHealth and UHealth, 6(10), e10291. https://doi.org/10.2196/10291
  • Wiggins, A., & Wilbanks, J. (2019). The rise of citizen science in health and biomedical research. The American Journal of Bioethics, 19(8), 3–14. https://doi.org/10.1080/15265161.2019.1619859